期刊文献+

多索茶碱在大鼠体内的时辰药动学

The chronopharmacokinetics of doxofylline in rats
原文传递
导出
摘要 目的:观察多索茶碱不同时间给药的药动学差异。方法:16只大鼠在8∶00,20∶00两个不同时间点,按80.0mg.kg-1多索茶碱口服给药,于0.08,0.25,0.5,1.0,1.5,2.0,3.0,5.0,7.0h后取血,分别测定其血浆药物浓度,并按非房室模型计算药动学参数。结果:大鼠于8∶00和20∶00给药,其药动学的主要参数t1/2、AUC(0-7)、MRT(0-7)、Vz/F、CL/F、tmax、Cmax等差异无显著性(P>0.05)。结论:多索茶碱在大鼠体内的药动学参数没有明显的昼夜节律性变化。 OBJECTIVE To observe the change of pharmacokinetics of doxofylline in rats by single oral administration at different time. METHODS Sixteen rats were given a single dose of doxofylline 80 mg·kg^-1 at 8 : 00 and 20: 00 respectively. The blood was taken out at 0. 08,0. 25,0. 5,1.0, 1.5,2. 0,3. 0,5. 0,7. 0 h. The concentrations of doxofylline in plasma was determined and the pharmacokinetic parameters of non-compartment model were calculated. RESULTS The main pharmacokinetic parameters of doxofylline t 1/2 ,AUC(0-7)、MRT(0-7)、Vz/F、CL/F、Tmax、Cmax were not significantly different in rats by oral administration at 8:00 and 20:00(P〉0. 05). CONCLUSION The pharmacokinetics of doxofylline has no obvious change in circadian rhythms in rats.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第23期2009-2011,共3页 Chinese Journal of Hospital Pharmacy
关键词 多索茶碱 药动学 时间节律 高效液相色谱法 doxofylline pharmacokinetics circadian rhythms HPLC
  • 相关文献

参考文献6

二级参考文献26

  • 1施毅,康晓明,储小曼,夏锡荣,卓海通,刘堃.环丙沙星和氧氟沙星对氨茶碱药代动力学的影响[J].中国临床药理学杂志,1994,10(4):206-210. 被引量:13
  • 2钟淑卿 莫红樱 张永昶 等.氟喹诺酮类对缓释茶碱茶喘平药动学的影响[J].中华结核和呼吸杂志,1995,18(4):240-240. 被引量:1
  • 3Stab H. Moxifloxacin-review of clinical pharrnacokinetics metabolism and excretion,Poster at First International Moxiflixacia Symposium[ C ]. Berlin: Bayer, 1993,3 : 1986. 被引量:1
  • 4Stass H, Dalhoff A, Kubitza D, et al. Pharmacokinetics, safety,and tolerbility of ascending single doses of Moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects[J]. Antimicrob Agents Chemothe , 1998,42(8) :2060. 被引量:1
  • 5Villani F, Maria PD, Ronchi E, et al. Oral doxophylline in patients with chronic obstructive pulmonary disease[J]. Int J Clin Pharmacol Ther, 1997,35(3) : 107. 被引量:1
  • 6Wise R. Areview of the clinical pharmacology of moxifloxaein, a new 8-methoxyquinμLone, and its potentiμL relation to therapeutic effieacy[ J ]. Clin Druw lnvest. 1999.17 (5) : 365. 被引量:1
  • 7Franzone JS, Cravanzola C, Masera F. Preliminary studies of the absorption, distribution and excretion of 2-( 7 '-theophyllinernethyl)-1, 3-dioxolane in rat[J]. Farmaco ( Sci ), 1981,36(3) :220. 被引量:1
  • 8Grosa G, Franzone JS, Biglino G. Metabolism of doxofylline by rat liver microsomes[J]. Am Sci Pharmacol & Exp Ther,1986,14(2) :33. 被引量:1
  • 9Lagana A, Bizzarri M,Marino A,et al. Solid phase extraction and high performance liquid chromatographic determination of doxophylline in plasma[J]. Biomed Chromatogr, 1990,4(5) :205. 被引量:1
  • 10陈刚,治疗药物监测,1988年 被引量:1

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部